This inhibitory effect is significant in cancer development and progression as it promotes an immunosuppressive tumor environment, making Cbl-b an attractive therapeutic target for cancer immunotherapy, as well as other human immune-related disorders including infections and autoimmune diseases11,22. The gene discussed is CBLB; the disease is cancer.